Literature DB >> 31102408

Serum metabolic signatures of coronary and carotid atherosclerosis and subsequent cardiovascular disease.

Ioanna Tzoulaki1,2,3,4, Raphaële Castagné1,5, Claire L Boulangé6,7, Ibrahim Karaman1,2,4, Elena Chekmeneva7, Evangelos Evangelou1,2,3, Timothy M D Ebbels7, Manuja R Kaluarachchi6,7, Marc Chadeau-Hyam1,2, David Mosen1,2, Abbas Dehghan1,2,4, Alireza Moayyeri8, Diana L Santos Ferreira9, Xiuqing Guo10,11, Jerome I Rotter10,11, Kent D Taylor10,11, Maryam Kavousi12, Paul S de Vries12,13, Benjamin Lehne1, Marie Loh1, Albert Hofman12,14, Jeremy K Nicholson6,7, John Chambers1,15, Christian Gieger16, Elaine Holmes6,7, Russell Tracy17, Jaspal Kooner14,18, Philip Greenland19, Oscar H Franco11,20, David Herrington21, John C Lindon6,7, Paul Elliott1,2,4.   

Abstract

AIMS: To characterize serum metabolic signatures associated with atherosclerosis in the coronary or carotid arteries and subsequently their association with incident cardiovascular disease (CVD). METHODS AND
RESULTS: We used untargeted one-dimensional (1D) serum metabolic profiling by proton nuclear magnetic resonance spectroscopy (1H NMR) among 3867 participants from the Multi-Ethnic Study of Atherosclerosis (MESA), with replication among 3569 participants from the Rotterdam and LOLIPOP studies. Atherosclerosis was assessed by coronary artery calcium (CAC) and carotid intima-media thickness (IMT). We used multivariable linear regression to evaluate associations between NMR features and atherosclerosis accounting for multiplicity of comparisons. We then examined associations between metabolites associated with atherosclerosis and incident CVD available in MESA and Rotterdam and explored molecular networks through bioinformatics analyses. Overall, 30 1H NMR measured metabolites were associated with CAC and/or IMT, P = 1.3 × 10-14 to 1.0 × 10-6 (discovery) and P = 5.6 × 10-10 to 1.1 × 10-2 (replication). These associations were substantially attenuated after adjustment for conventional cardiovascular risk factors. Metabolites associated with atherosclerosis revealed disturbances in lipid and carbohydrate metabolism, branched chain, and aromatic amino acid metabolism, as well as oxidative stress and inflammatory pathways. Analyses of incident CVD events showed inverse associations with creatine, creatinine, and phenylalanine, and direct associations with mannose, acetaminophen-glucuronide, and lactate as well as apolipoprotein B (P < 0.05).
CONCLUSION: Metabolites associated with atherosclerosis were largely consistent between the two vascular beds (coronary and carotid arteries) and predominantly tag pathways that overlap with the known cardiovascular risk factors. We present an integrated systems network that highlights a series of inter-connected pathways underlying atherosclerosis.
© The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology.

Entities:  

Keywords:  Atherosclerosis; Coronary artery calcium; Epidemiological studies; Intima-media thickness; Metabolic phenotyping; Metabolomics

Mesh:

Year:  2019        PMID: 31102408      PMCID: PMC7963131          DOI: 10.1093/eurheartj/ehz235

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  48 in total

1.  The Rotterdam Study: 2016 objectives and design update.

Authors:  Albert Hofman; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2015-09-19       Impact factor: 8.082

2.  A metabolomic profile is associated with the risk of incident coronary heart disease.

Authors:  Anika A M Vaarhorst; Aswin Verhoeven; Claudia M Weller; Stefan Böhringer; Sibel Göraler; Axel Meissner; André M Deelder; Peter Henneman; Anton P M Gorgels; Piet A van den Brandt; Leo J Schouten; Marleen M van Greevenbroek; Audrey H H Merry; W M Monique Verschuren; Arn M J M van den Maagdenberg; Ko Willems van Dijk; Aaron Isaacs; Dorret Boomsma; Ben A Oostra; Cornelia M van Duijn; J Wouter Jukema; Jolanda M A Boer; Edith Feskens; Bastiaan T Heijmans; P Eline Slagboom
Journal:  Am Heart J       Date:  2014-04-04       Impact factor: 4.749

3.  Metabolic profiling and the metabolome-wide association study: significance level for biomarker identification.

Authors:  Marc Chadeau-Hyam; Timothy M D Ebbels; Ian J Brown; Queenie Chan; Jeremiah Stamler; Chiang Ching Huang; Martha L Daviglus; Hirotsugu Ueshima; Liancheng Zhao; Elaine Holmes; Jeremy K Nicholson; Paul Elliott; Maria De Iorio
Journal:  J Proteome Res       Date:  2010-09-03       Impact factor: 4.466

4.  Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI).

Authors:  Lloyd W Sumner; Alexander Amberg; Dave Barrett; Michael H Beale; Richard Beger; Clare A Daykin; Teresa W-M Fan; Oliver Fiehn; Royston Goodacre; Julian L Griffin; Thomas Hankemeier; Nigel Hardy; James Harnly; Richard Higashi; Joachim Kopka; Andrew N Lane; John C Lindon; Philip Marriott; Andrew W Nicholls; Michael D Reily; John J Thaden; Mark R Viant
Journal:  Metabolomics       Date:  2007-09       Impact factor: 4.290

5.  Precision high-throughput proton NMR spectroscopy of human urine, serum, and plasma for large-scale metabolic phenotyping.

Authors:  Anthony C Dona; Beatriz Jiménez; Hartmut Schäfer; Eberhard Humpfer; Manfred Spraul; Matthew R Lewis; Jake T M Pearce; Elaine Holmes; John C Lindon; Jeremy K Nicholson
Journal:  Anal Chem       Date:  2014-09-16       Impact factor: 6.986

Review 6.  Design and analysis of metabolomics studies in epidemiologic research: a primer on -omic technologies.

Authors:  Ioanna Tzoulaki; Timothy M D Ebbels; Ana Valdes; Paul Elliott; John P A Ioannidis
Journal:  Am J Epidemiol       Date:  2014-06-24       Impact factor: 4.897

7.  Methods of data collection and definitions of cardiac outcomes in the Rotterdam Study.

Authors:  Maarten J G Leening; Maryam Kavousi; Jan Heeringa; Frank J A van Rooij; Jolande Verkroost-van Heemst; Jaap W Deckers; Francesco U S Mattace-Raso; Gijsbertus Ziere; Albert Hofman; Bruno H Ch Stricker; Jacqueline C M Witteman
Journal:  Eur J Epidemiol       Date:  2012-03-03       Impact factor: 8.082

8.  Causal analysis approaches in Ingenuity Pathway Analysis.

Authors:  Andreas Krämer; Jeff Green; Jack Pollard; Stuart Tugendreich
Journal:  Bioinformatics       Date:  2013-12-13       Impact factor: 6.937

9.  Improving Visualization and Interpretation of Metabolome-Wide Association Studies: An Application in a Population-Based Cohort Using Untargeted 1H NMR Metabolic Profiling.

Authors:  Raphaële Castagné; Claire Laurence Boulangé; Ibrahim Karaman; Gianluca Campanella; Diana L Santos Ferreira; Manuja R Kaluarachchi; Benjamin Lehne; Alireza Moayyeri; Matthew R Lewis; Konstantina Spagou; Anthony C Dona; Vangelis Evangelos; Russell Tracy; Philip Greenland; John C Lindon; David Herrington; Timothy M D Ebbels; Paul Elliott; Ioanna Tzoulaki; Marc Chadeau-Hyam
Journal:  J Proteome Res       Date:  2017-09-08       Impact factor: 4.466

10.  Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: an observational study of 17,345 persons.

Authors:  Krista Fischer; Johannes Kettunen; Peter Würtz; Toomas Haller; Aki S Havulinna; Antti J Kangas; Pasi Soininen; Tõnu Esko; Mari-Liis Tammesoo; Reedik Mägi; Steven Smit; Aarno Palotie; Samuli Ripatti; Veikko Salomaa; Mika Ala-Korpela; Markus Perola; Andres Metspalu
Journal:  PLoS Med       Date:  2014-02-25       Impact factor: 11.069

View more
  27 in total

1.  Extracellular vesicles carrying proinflammatory factors may spread atherosclerosis to remote locations.

Authors:  Mengna Peng; Rui Sun; Ye Hong; Jia Wang; Yi Xie; Xiaohao Zhang; Juanji Li; Hongquan Guo; Pengfei Xu; Yunzi Li; Xiaoke Wang; Ting Wan; Ying Zhao; Feihong Huang; Yuhui Wang; Ruidong Ye; Qian Liu; George Liu; Xinfeng Liu; Gelin Xu
Journal:  Cell Mol Life Sci       Date:  2022-07-18       Impact factor: 9.207

2.  The newborn metabolome: associations with gestational diabetes, sex, gestation, birth mode, and birth weight.

Authors:  David Burgner; Richard Saffery; Toby Mansell; Amanda Vlahos; Fiona Collier; Anne-Louise Ponsonby; Peter Vuillermin; Susan Ellul; Mimi L K Tang
Journal:  Pediatr Res       Date:  2021-09-15       Impact factor: 3.953

3.  Identification of Metabolomics Biomarkers in Extracranial Carotid Artery Stenosis.

Authors:  Chia-Ni Lin; Kai-Cheng Hsu; Kuo-Lun Huang; Wen-Cheng Huang; Yi-Lun Hung; Tsong-Hai Lee
Journal:  Cells       Date:  2022-09-27       Impact factor: 7.666

Review 4.  Metabolic Reprogramming in Immune Response and Tissue Inflammation.

Authors:  Lizhe Sun (孙李哲); Xiaofeng Yang (杨晓峰); Zuyi Yuan (袁祖贻); Hong Wang (王虹)
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-07-23       Impact factor: 8.311

5.  Metabolites from midtrimester plasma of pregnant patients at high risk for preterm birth.

Authors:  Tracy A Manuck; Yunjia Lai; Hongyu Ru; Angelica V Glover; Julia E Rager; Rebecca C Fry; Kun Lu
Journal:  Am J Obstet Gynecol MFM       Date:  2021-05-12

6.  Associations of circulating choline and its related metabolites with cardiometabolic biomarkers: an international pooled analysis.

Authors:  Xiong-Fei Pan; Jae Jeong Yang; Xiao-Ou Shu; Steven C Moore; Nicholette D Palmer; Marta Guasch-Ferré; David M Herrington; Sei Harada; Heather Eliassen; Thomas J Wang; Robert E Gerszten; Demetrius Albanes; Ioanna Tzoulaki; Ibrahim Karaman; Paul Elliott; Huilian Zhu; Lynne E Wagenknecht; Wei Zheng; Hui Cai; Qiuyin Cai; Charles E Matthews; Cristina Menni; Katie A Meyer; Loren P Lipworth; Jennifer Ose; Myriam Fornage; Cornelia M Ulrich; Danxia Yu
Journal:  Am J Clin Nutr       Date:  2021-09-01       Impact factor: 8.472

7.  Circulating trimethylamine N-oxide in association with diet and cardiometabolic biomarkers: an international pooled analysis.

Authors:  Jae Jeong Yang; Xiao-Ou Shu; David M Herrington; Steven C Moore; Katie A Meyer; Jennifer Ose; Cristina Menni; Nicholette D Palmer; Heather Eliassen; Sei Harada; Ioanna Tzoulaki; Huilian Zhu; Demetrius Albanes; Thomas J Wang; Wei Zheng; Hui Cai; Cornelia M Ulrich; Marta Guasch-Ferré; Ibrahim Karaman; Myriam Fornage; Qiuyin Cai; Charles E Matthews; Lynne E Wagenknecht; Paul Elliott; Robert E Gerszten; Danxia Yu
Journal:  Am J Clin Nutr       Date:  2021-05-08       Impact factor: 8.472

8.  What we know about protein gut metabolites: Implications and insights for human health and diseases.

Authors:  José de Jesús Rodríguez-Romero; Alba Cecilia Durán-Castañeda; Alicia Paulina Cárdenas-Castro; Jorge Alberto Sánchez-Burgos; Victor Manuel Zamora-Gasga; Sonia Guadalupe Sáyago-Ayerdi
Journal:  Food Chem X       Date:  2021-12-22

Review 9.  Toward a Standardized Strategy of Clinical Metabolomics for the Advancement of Precision Medicine.

Authors:  Nguyen Phuoc Long; Tran Diem Nghi; Yun Pyo Kang; Nguyen Hoang Anh; Hyung Min Kim; Sang Ki Park; Sung Won Kwon
Journal:  Metabolites       Date:  2020-01-29

10.  Objectives, design and main findings until 2020 from the Rotterdam Study.

Authors:  M Arfan Ikram; Guy Brusselle; Mohsen Ghanbari; André Goedegebure; M Kamran Ikram; Maryam Kavousi; Brenda C T Kieboom; Caroline C W Klaver; Robert J de Knegt; Annemarie I Luik; Tamar E C Nijsten; Robin P Peeters; Frank J A van Rooij; Bruno H Stricker; André G Uitterlinden; Meike W Vernooij; Trudy Voortman
Journal:  Eur J Epidemiol       Date:  2020-05-04       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.